✦ LIBER ✦

A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer

✍ Scribed by Slovin, Susan F.; Kehoe, Marissa; Durso, Robert; Fernandez, Celina; Olson, William; Gao, Jian P.; Israel, Robert; Scher, Howard I.; Morris, Stephen

Book ID: 121391973
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 726 KB
Volume: 31
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2012.11.096

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of DNA vaccination with

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer

✍ Pavlenko, M; Roos, A-K; Lundqvist, A; Palmborg, A; Miller, A M; Ozenci, V; Bergm 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

PHASE 2a TRIAL OF 177LUTETIUM RADIOLABEL

PHASE 2a TRIAL OF 177LUTETIUM RADIOLABELED ANTI- PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) MONOCLONAL ANTIBODY J591 (177Lu-J591) IN PATIENTS (PTS) WITH METASTATIC ANDROGEN-INDEPENDENT PROSTATE CANCER (AIPC)

✍ Bander, Neil H; Nanus, David M; Tagawa, Scott; Vallabhajosula, Shankar; Goldsmit 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 125 KB

Phase I Trial of 177Lutetium-Labeled J59

Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

✍ Walsh, Patrick C. 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 52 KB

Phase I rapid dose-escalation study of A

Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial

✍ Emmanuel S. Antonarakis; Michael A. Carducci; Mario A. Eisenberger; Samuel R. De 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 316 KB